{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:04:02Z","timestamp":1791227042969,"version":"4.1.0"},"reference-count":35,"publisher":"European Respiratory Society (ERS)","issue":"5","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2023,7,6]]},"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cardiomyopathy has become an important life-limiting factor since survival in Duchenne muscular dystrophy (DMD) has greatly increased with long-term ventilation and cough assistance. The aim of this study was to investigate the association between impaired left ventricular ejection fraction (LVEF) and survival.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a &gt;20-year observational study in patients with DMD (age \u226516\u2005years) with at least three echocardiograms, the association between LVEF and survival and time to cardiac or non-cardiac death was investigated using Kaplan\u2013Meier survival analysis and Cox regression (for LVEF).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In 67 DMD patients (430 echocardiograms), the decrease in LVEF over a mean\u00b1<jats:sc>sd<\/jats:sc>follow-up period of 9.1\u00b15.1\u2005years was \u221210.0\u00b113.9% absolute, but LVEF progression varied widely. 84% were receiving an angiotensin-converting enzyme inhibitor and 54% a \u03b2-blocker at last follow-up with an LVEF of 37.5\u00b112.4% at that time-point. Median (interquartile range) survival was 33 (25\u201340)\u2005years. 28 out of 67 (42%) of the cohort had died and LVEF was a significant negative predictor of survival (hazard ratio 0.95 (95% CI 0.91\u20130.99); p&lt;0.007). Those who died of cardiac death (53% of known causes of death) had significantly lower LVEF at the time of death (LVEF \u221211.0% (95% CI \u221221.1\u2013\u2009\u22120.9%); p=0.035) compared with non-cardiac death and tended to die at a younger age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Cardiomyopathy with systolic heart failure is the leading cause of death and lower LVEF is an independent predictor of mortality at younger ages in patients with DMD. Patients with DMD appear to be undertreated with respect to heart failure drug therapy.<\/jats:p><\/jats:sec>","DOI":"10.1183\/23120541.00176-2023","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T14:20:58Z","timestamp":1689258058000},"page":"00176-2023","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["Cardiomyopathy as cause of death in Duchenne muscular dystrophy: a longitudinal observational study"],"prefix":"10.1183","volume":"9","author":[{"given":"Annabel","family":"Lechner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00ebl J.","family":"Herzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4253-2140","authenticated-orcid":false,"given":"Jacqueline G.","family":"Kientsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Kohler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad E.","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5250-5022","authenticated-orcid":false,"given":"Silvia","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther I.","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"2024101712030738000_9.5.00176-2023.1","doi-asserted-by":"publisher","DOI":"10.1016\/0960-8966(91)90039-U"},{"key":"2024101712030738000_9.5.00176-2023.2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(87)90579-4"},{"key":"2024101712030738000_9.5.00176-2023.3","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.21254"},{"key":"2024101712030738000_9.5.00176-2023.4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30025-5"},{"key":"2024101712030738000_9.5.00176-2023.5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2213-2600(21)00581-6","article-title":"Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges","volume":"10","author":"Birnkrant","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2024101712030738000_9.5.00176-2023.6","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01862-w"},{"key":"2024101712030738000_9.5.00176-2023.7","doi-asserted-by":"publisher","DOI":"10.1136\/thx.53.11.949"},{"key":"2024101712030738000_9.5.00176-2023.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2010.09.006"},{"key":"2024101712030738000_9.5.00176-2023.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(02)00140-2"},{"key":"2024101712030738000_9.5.00176-2023.10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nmd.2022.04.008","article-title":"Selected clinical and demographic factors and all-cause mortality among individuals with Duchenne muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking, and Research Network","volume":"32","author":"Paramsothy","year":"2022","journal-title":"Neuromuscul Disord"},{"key":"2024101712030738000_9.5.00176-2023.11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10654-021-00819-4","article-title":"One in five patients with Duchenne muscular dystrophy dies from other causes than cardiac or respiratory failure","volume":"37","author":"Wahlgren","year":"2022","journal-title":"Eur J Epidemiol"},{"key":"2024101712030738000_9.5.00176-2023.12","doi-asserted-by":"crossref","first-page":"e2304","DOI":"10.1212\/WNL.0000000000012910","article-title":"Life expectancy in Duchenne muscular dystrophy: reproduced individual patient data meta-analysis","volume":"97","author":"Broomfield","year":"2021","journal-title":"Neurology"},{"key":"2024101712030738000_9.5.00176-2023.13","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.141721"},{"key":"2024101712030738000_9.5.00176-2023.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200503-322OC"},{"key":"2024101712030738000_9.5.00176-2023.15","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.00831"},{"key":"2024101712030738000_9.5.00176-2023.16","doi-asserted-by":"crossref","first-page":"e0163779","DOI":"10.1371\/journal.pone.0163779","article-title":"Gastrointestinal dysfunction in patients with Duchenne muscular dystrophy","volume":"11","author":"Cascio CM","year":"2016","journal-title":"PLoS One"},{"key":"2024101712030738000_9.5.00176-2023.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00292-017-0265-1"},{"key":"2024101712030738000_9.5.00176-2023.18","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201200578"},{"key":"2024101712030738000_9.5.00176-2023.19","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(98)00030-8"},{"key":"2024101712030738000_9.5.00176-2023.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70414-X"},{"key":"2024101712030738000_9.5.00176-2023.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2008.08.013"},{"key":"2024101712030738000_9.5.00176-2023.22","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23215"},{"key":"2024101712030738000_9.5.00176-2023.23","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1002\/ehf2.13970","article-title":"The association between cardiac involvement and long-term clinical outcomes in patients with Duchenne muscular dystrophy","volume":"9","author":"Cha","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2024101712030738000_9.5.00176-2023.24","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2024101712030738000_9.5.00176-2023.25","doi-asserted-by":"crossref","first-page":"812","DOI":"10.21037\/jtd-22-1528","article-title":"Cardioprotective medication in Duchenne muscular dystrophy: a single-centre cohort study","volume":"15","author":"Kisel","year":"2023","journal-title":"J Thorac Dis"},{"key":"2024101712030738000_9.5.00176-2023.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-8966(02)00213-4"},{"key":"2024101712030738000_9.5.00176-2023.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.05.014"},{"key":"2024101712030738000_9.5.00176-2023.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.09.078"},{"key":"2024101712030738000_9.5.00176-2023.29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.528281"},{"key":"2024101712030738000_9.5.00176-2023.30","first-page":"ecurrents.md.2cc69a1dae4be7dfe2b","article-title":"A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy","volume":"5","author":"Allen","year":"2013","journal-title":"PLoS Curr"},{"key":"2024101712030738000_9.5.00176-2023.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.02.064"},{"key":"2024101712030738000_9.5.00176-2023.32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70318-7"},{"key":"2024101712030738000_9.5.00176-2023.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2008.03.002"},{"key":"2024101712030738000_9.5.00176-2023.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32160-8"},{"key":"2024101712030738000_9.5.00176-2023.35","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-003-1675-5","article-title":"Evaluation of health-related quality of life using the MOS 36-Item Short-Form Health Status Survey in patients receiving noninvasive positive pressure ventilation","volume":"29","author":"Windisch","year":"2003","journal-title":"Intensive Care Med"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00176-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:29:21Z","timestamp":1740374961000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00176-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,9,18]]},"published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1183\/23120541.00176-2023"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00176-2023","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]}}}